Tradestie Institutional Equity Comparison Engine

OKUR vs ASMB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OKUR Overall Edge

OKUR Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OnKure Therapeutics, Inc. Class A Common Stock (OKUR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ASMB counters with relative strength in Valuation. Fundamentally, OKUR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ASMB at N/M Forward P/E and -31.8% operating margin (-72.6% YoY). In options structure, OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro) against ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASMB
OKUR N/M vs ASMB N/M Fwd P/E
Growth & Margin Winner OKUR
Op Margin 0.0% vs -31.8% ยท YoY +0.0% vs -72.6%
Momentum & Technical Winner OKUR
1Y -2.2% vs -41.6% ยท 52W Pos 20% vs 15%
Options & Structure Winner OKUR
SURGE (100th %ile IV) vs UNCLASSIFIED (100th %ile IV)
OKUR NASDAQ
OnKure Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$2.70
-2.17% 1D
Market Cap $113.7M
1M Return +4.65%
1Y Return -2.17%
Forward P/E N/M
Unified AI Score
36.0 / 100 SELL
Tech 20.0 Fund 46.0 Flow 64.0 Mom 60.0
ASMB NASDAQ
Assembly Biosciences, Inc
Pharmaceutical Preparations
$22.19
-1.38% 1D
Market Cap $460.7M
1M Return +9.42%
1Y Return -41.61%
Forward P/E N/M
Unified AI Score
30.4 / 100 SELL
Tech 20.0 Fund 31.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OKUR -2.17% ASMB -41.61% Spread: +39.44 pp (OKUR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OKUR TTM Op. Margin: 0.0% ASMB TTM Op. Margin: -31.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKUR vs ASMB. Trailing 12-month operating profitability (OKUR 0.0% vs ASMB -31.8%) and valuation multiples (OKUR N/M vs ASMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OKUR (5) vs ASMB (4)
Institutional Metric OKUR ASMB Criterion Row Winner
Market Capitalization Scale $113.7M $460.7M Larger Scale ASMB
Trailing P/E Ratio Valuation N/M 30.0x Lower Multiple ASMB
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -72.6% Higher Growth OKUR
Operating Margin (TTM) Profitability 0.0% -31.8% Higher Margin OKUR
Net Profit Margin Profitability 0.0% -16.6% Higher Margin OKUR
Return on Equity (ROE) Capital Efficiency -55.2% -4.6% Higher ROE ASMB
52-Week Range Position Momentum 20% ($2โ€“$5) 15% ($19โ€“$40) Stronger Trend OKUR
Beta / 30D Volatility Risk Regime 0.96ฮฒ ยท 100% Vol 0.92ฮฒ ยท 57% Vol Lower Realized Risk ASMB
Unified Institutional Score Composite Signal 36.0 / 100 (SELL) 30.4 / 100 (SELL) Higher Composite OKUR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OKUR vs ASMB Buy Guide
OKUR SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live OKUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASMB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ASMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OKUR nor ASMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.